Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.290
0.00 (0.00%)
At close: Jun 5, 2025, 4:00 PM
1.280
-0.010 (-0.78%)
After-hours: Jun 5, 2025, 5:02 PM EDT
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $283.26 million as of June 5, 2025. Its market cap has decreased by -51.02% in one year.
Market Cap
283.26M
Enterprise Value
91.04M
1-Year Change
-51.02%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $283.26M, a decrease of -90.17%. That is a compound annual growth rate of -29.44%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 684.94B |
Johnson & Johnson | 368.90B |
AbbVie | 331.62B |
Novo Nordisk | 324.15B |
UnitedHealth Group | 270.36B |
Abbott Laboratories | 232.08B |
Novartis AG | 229.87B |
AstraZeneca | 226.47B |